Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

GSK staff tagged with bribery, tax violation allegations in China
August 2013
SHARING OPTIONS:

BEIJING—The Chinese Ministry of Public Security has announced that a probe in Changsha, Shanghai and Zhengzhou alleges that some GlaxoSmithKline PLC (GSK) executives attempted to create new sales channels and increase drug prices in China by bribing government officials, pharmaceutical industry associations, hospitals and doctors. GSK staff also allegedly used fake receipts in unspecified tax law violations. In June, GSK said it found no proof of wrongdoing after it investigated allegations that its sales staff in China was involved in bribing doctors between 2004 and 2010. GSK said that while it had "found no evidence of bribery or corruption of doctors or government officials" while monitoring its businesses, "if evidence of such activity is provided, we will act swiftly on it."    

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2019 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.